We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$111M
AUM Growth
+$31.4M
Cap. Flow
+$30.1M
Cap. Flow %
27.21%
Top 10 Hldgs %
89.23%
Holding
35
New
14
Increased
1
Reduced
–
Closed
9

Top Buys

Rank Stock Value
1
RUBY
Rubius Therapeutics, Inc
RUBY
+$22.6M
2
SNAP icon
Snap
SNAP
+$4.52M
3
COUP
Coupa Software Incorporated
COUP
+$4.44M
4
ZUO
Zuora, Inc.
ZUO
+$4.37M
5
YEXT icon
Yext
YEXT
+$2.63M

Top Sells

Rank Stock Value
1
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$8.05M
2
RDFN
Redfin
RDFN
+$3.4M
3
FSCT
ForeScout Technologies, Inc. Common Stock
FSCT
+$2.09M
4
ALRM icon
Alarm.com
ALRM
+$1.2M
5
TSLA icon
Tesla
TSLA
+$1.09M

Sector Composition

Rank Sector Weight
1 Healthcare 46.46%
2 Technology 13.13%
3 Financials 8.7%
4 Communication Services 7.75%
5 Consumer Discretionary 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKAO
26
DELISTED
Achaogen Inc
AKAO
$80K 0.07%
20,000
– –
ALRM icon
27
Alarm.com
ALRM
$2.7B
– –
-29,618
Closed -$1.2M
ATEC icon
28
Alphatec Holdings
ATEC
$1.43B
– –
-28,074
Closed -$84K
RDFN
29
DELISTED
Redfin
RDFN
– –
-147,098
Closed -$3.4M
TSLA icon
30
Tesla
TSLA
$1.21T
– –
-47,625
Closed -$1.09M
WOW
31
DELISTED
WideOpenWest
WOW
– –
-99,377
Closed -$960K
AGTC
32
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-23,356
Closed -$86K
CLDR
33
DELISTED
Cloudera, Inc.
CLDR
– –
-64,768
Closed -$883K
MYOK
34
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-162,131
Closed -$8.05M
FSCT
35
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
– –
-60,898
Closed -$2.09M
1
2

Similar funds

VCM
Vines Capital Management Monroe, Louisiana $101M AUM
TCI
Triveni Capital Investments Stamford, Connecticut $101M AUM
RPC
Royal Palms Capital Whitefish, Montana $101M AUM
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
AWA
Ark Wealth Advisors Yorba Linda, California $101M AUM
HWM
Hobbs Wealth Management Zionsville, Indiana $101M AUM 22.3% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
ROP
Rule One Partners Moreland, Georgia $101M AUM 6.3% 1-Year Est. Return

Harbourvest Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Harbourvest Partners held 35 positions worth $111M, up 40% from $79.2M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Harbourvest Partners deployed $30.1M of net new capital in Q3 2018, opening 14 new positions and adding to 1 existing holding. Its largest new stake was Rubius Therapeutics, Inc: 986,878 shares worth $23.7M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.

On the sell side, the most notable exit was MyoKardia, Inc. Common Stock, an estimated $8.05M sold.

  • Harbourvest Partners's largest Q3 2018 buy was Rubius Therapeutics, Inc: 986,878 shares worth $23.7M.
  • Harbourvest Partners added most to Snap in Q3 2018, an estimated $4.52M increase.
  • Harbourvest Partners fully exited MyoKardia, Inc. Common Stock in Q3 2018, selling an estimated $8.05M.
  • Harbourvest Partners's ten largest holdings make up 89% of its $111M portfolio in Q3 2018.
  • Harbourvest Partners opened 14 new positions and closed 9 in Q3 2018.
  • Harbourvest Partners's portfolio value rose 40% quarter-over-quarter to $111M.

Based on Harbourvest Partners's 13F filing for Q3 2018, filed 14 Nov 2018.